期刊文献+

冠心病合并慢性心力衰竭患者血管性血友病因子水平的变化 被引量:1

Change of von Willebrand Factor in Patients with Coronary Heart Disease in Association with Heart Failure
下载PDF
导出
摘要 目的探讨冠心病合并慢性心力衰竭患者血清中血管性血友病因子(von Willebrand factor,vWF)的变化和临床意义。方法选取确诊冠心病患者57例和同期健康人30例作为对照组,抽取静脉血,采用酶联吸附法测定血清中vWF含量,并按心功能等级分级进行比较分析。结果冠心病合并慢性心力衰竭患者血清中vWF显著升高(P<0.01),并随着心衰加重而越显著(P<0.01),心功能Ⅲ、Ⅳ级与Ⅱ级比较显著升高(P<0.01),心衰程度与血清中vWF呈正相关关系(r=0.43,P<0.01)。结论冠心病合并慢性心力衰竭患者血清中vWF水平升高,检测血清中vWF可作为评价其病情严重程度的指标之一。 Objective To investigate the change and significance of von Willebrand factor(vWF) in patients with coronary heart disease in association with heart failure.MethodsThe level of vWF in plasma of 57 patients with coronary heart disease in association with heart failure and 30 normal persons were determined.According to the heart function the patients were divided into three groups.ResultsThe plasma levels of vWF of patients with coronary heart disease in association with heart failure were significantly higher than control group(P〈0.01),the poorer the heart function,the higher was vWF levels.The plasma levels of vWF of patients with cardiac function of class Ⅲ and Ⅳ were significantly higher than those of patients with cardiac function of class Ⅱ(P〈0.01).The plasma level of vWF had a positive correlation with the degree of chronic heart failure(P〈0.01).ConclusionThe plasma levels of vWF of patients with coronary heart disease in association with heart failure were high,The plasma levels of vWF might be important predicators of the severity of coronary heart disease in association with heart failure.
出处 《血栓与止血学》 2008年第2期69-70,73,共3页 Chinese Journal of Thrombosis and Hemostasis
基金 广东省自然科学基金资助项目(05002857)
关键词 冠心病 心力衰竭 血管性血友病因子 Coronary heart disease Heart failure Von Willebrand factor
  • 相关文献

参考文献10

二级参考文献47

  • 1张琳,崔让庄,毛用敏,朱天慧.人血DNA的提取方法[J].天津医药,1993,21(2):112-114. 被引量:5
  • 2Boger RH, Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia[J]. Circulation, 1998, 98(18): 1842-1847.
  • 3Ito A, Tsao PS, Adimolam S, et al. Novel mechanism for endothelial dysfunction: dysfunction of dimethylargine dimethylamineohydrolase[J]. Circulation, 1999,(24): 3092-3095.
  • 4Jaffe EA, Nachman RL, Becker CG. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria[J]. J Clin Invest, 1973, 52(11): 2745-2756.
  • 5Rudic RD, Shescly EG, Maeda N, et al. Direct evidence for the importance of endothelium derived nitric oxide in vascular remodeling[J]. J Clin Invest, 1998, 101(4): 731-736.
  • 6Boger RH, Sydow K, Borlak J, et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginnine in human endothelial cells involvement of sdenosylmethionine-dependent methyltransferases[J]. Circulation, 2000, 87(2): 99-105.
  • 7Faraci FM, Brian JE, Heistad DD. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase[J]. Am J Physiol, 1995, 269(5pt2): H1522-H1527.
  • 8Ito A, Egashira K, Narishige T, et al. Renin-angiotensin system in involved in the mechanism of increased serum asymmetric dimethylarginime in essential hypertension[J]. Jpn Circ J, 2001, 65(9): 775-778.
  • 9Ambarus V,Rezus C,Ghiuru R,et al. The implications of thromboembolism in chronic heart failure. Rev. Med Chir Soc Med Nat Iasi, 2002,106:107-111.
  • 10Heinke MY, Wheeler CH, Yan JX, et al. Changesin myocardial protein expression in pacing-induced canine heart failure. Electrophoresis, 1999,20: 2086-2093.

共引文献27

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部